1. Common clinic scenarios

'Doctor, I'm 56, my cataract is getting bad enough to operate. I've worn glasses for ~2.0 D of astigmatism for years. After surgery, can I get rid of glasses? I've heard about a so-called toric IOL that costs an extra NT$ 20–30k or more out-of-pocket. Is it worth it?'

'Doctor, I had LASIK years ago and now have cataracts at 60. I've heard that post-LASIK cataract surgery is more complicated and less predictable. Can I still get a toric IOL?'

'Doctor, I have mild keratoconus and have worn RGP contacts for years. I'm starting to get cataracts. Can I have cataract surgery? Which IOL?'

All three scenarios involve toric IOLs. The first is the standard one; the second and third are 'special populations' where toric IOLs remain feasible but require extra workup. A June 2026 narrative review in American Journal of Ophthalmology (Verstraaten et al., ESCRS Functional Vision Working Group) synthesizes the past decade of toric IOL evidence — from basic indications and preoperative measurements to formulas, rotational stability, and these special populations — and is among the most thorough English-language reviews to date. This article digests its main points in clinic-friendly language and adds the Taiwan-specific NHI/self-pay reality.

2. Common patient Q&As

Q1: 'I have astigmatism — do I have to get a toric IOL with cataract surgery?'

A: No. International consensus is to consider a toric IOL when regular corneal astigmatism is ≥ 1.0 D AND the patient wants to be as spectacle-free as possible. Below 0.75 D, a standard monofocal usually suffices; 0.75–1.0 D is a grey zone — toric, monofocal + LRI, or monofocal + post-op glasses all valid. In Taiwan it's fully self-pay; discuss budget, lifestyle (night driving? reading? sports?) and your tolerance for glasses with your surgeon.

Q2: 'Is toric IOL better than LRI or FSAK?'

A: By the 'residual astigmatism ≤ 0.5 D' metric, toric IOLs do better. Cochrane 2019 (Lake et al., 10 RCTs, 626 toric vs 626 LRI eyes): toric ~70% reached ≤ 0.5 D, LRI ~50%; mean residual cylinder ~0.3 D lower with toric. Meta-analyses by Yen 2025 and Zhuo 2023 show similar superiority over FSAK, especially at moderate-to-high cylinder. LRI/FSAK pros: no extra IOL cost, can add onto a standard IOL. Cons: less correction power, less stable, can regress. Toric pros: accurate and stable correction. Cons: higher cost, demands precise intraoperative alignment, very rarely needs repositioning (~0.65%).

Q3: 'Will the toric IOL rotate? What if it does?'

A: Yes, but clinically significant rotation is uncommon. Modern toric IOLs stay within ±5° of target in 90–97% of eyes; ~0.65% need repositioning surgery (Oshika et al. 2018, 6,431-eye registry). Each 1° off-axis costs ~3.3% of the cylinder correction; > 10° usually warrants repositioning. The sweet spot for repositioning is postop day 7–14 — too early (1–2 days) and it tends to re-rotate; too late (> 4 weeks) and capsular fibrosis makes adjustment harder. Most repositioning is uneventful. Strategies to reduce rotation: choose the right IOL design (hydrophobic acrylic with appropriate haptic), precise intraoperative alignment (image-guided systems outperform manual ink marking), thorough OVD removal, appropriately sized capsulorhexis.

Q4: 'Can I still get a toric IOL after past LASIK/SMILE/PRK?'

A: Yes, but calculations are much more complex and results less predictable. Standard IOL formulas assume a normal anterior-to-posterior cornea ratio; refractive surgery has altered the anterior curvature, so standard formulas underestimate corneal power and create a hyperopic surprise. International consensus is to use post-refractive formulas: Barrett True-K Toric (uses direct posterior measurement), ASCRS Postrefractive Calculator, etc. With strict selection (regular bowtie pattern within central 3.0 mm, < 0.75 D difference between imaging techniques, axis difference < 15°), post-LASIK toric IOL implantation can yield good outcomes — but patients should be counseled that 'mild glasses or a future touch-up may still be needed.' See an ophthalmologist with explicit post-refractive cataract experience.

Q5: 'I have keratoconus — can I get a toric IOL?'

A: Yes, but with strict selection. International consensus: (1) stable ≥ 1 year (no recent progression or fresh crosslinking); (2) mild-to-moderate KC (refer severe KC for keratoplasty or RGP); (3) reproducible refraction; (4) KC-specific formulas (Barrett True-K KC P-PCA / M-PCA). Studies show selected patients gain significant UDVA and BCVA improvement; rotational stability matches the general population (especially hydrophobic acrylic IOLs). In highly myopic eyes, a capsular tension ring can further stabilize. Given the heterogeneity of KC, compare multiple formulas, and counsel patients that 'contacts or glasses may still be needed for full correction.'

Q6: 'Does Taiwan NHI cover toric IOLs? Roughly how much do they cost?'

A: ❌ NHI does NOT cover them. Taiwan's NHI drug coverage regulations don't include IOLs (IOLs are medical devices under separate 'special materials' regulations). NHI partially covers standard spherical IOLs (surgery fee + standard lens), but toric/EDOF/multifocal/trifocal IOLs are 'NHI + patient pays the difference'. Actual cost varies widely by brand and whether multifocal is bundled; we don't quote prices here — ask your ophthalmologist or clinic. Budget alternatives: (1) standard IOL + glasses with cylinder (fully NHI-covered, cheapest); (2) standard IOL + simultaneous LRI (offered at some centers). Don't choose 'upgrade' IOLs just because the name sounds premium — base your decision on your actual corneal astigmatism, lifestyle, budget, and an individualized discussion with your doctor.

Q7: 'After a toric IOL, will I still see halos, starbursts, glare?'

A: Depends on whether you choose monofocal toric or multifocal/EDOF toric. Monofocal toric: halo/glare similar to standard monofocal; mild negative dysphotopsia early postop in ~15–20%, usually resolving within 3–6 months; long-term persistent in only 0.5–2%. Multifocal toric: because light is split between foci, glare/halo is more common — ~50–77% notice halos or starbursts early; most adapt and severe interference with night driving or daily life remains uncommon (< 5%). If you drive frequently at night, are light-sensitive, or need fine contrast sensitivity, discuss monofocal toric instead. Significant IOL decentration/tilt can also induce higher-order aberrations and glare — that's an alignment problem, not the lens itself.

Q8: 'Can I have laser touch-up after a toric IOL?'

A: Yes, but usually wait at least 3 months for refractive stabilization. If significant residual cylinder or sphere remains and the IOL is well aligned, options include: (1) corneal laser touch-up (LASIK enhancement, PRK) — for smaller residual errors; (2) IOL exchange after recalculation or a piggyback IOL — for larger errors; (3) Light Adjustable Lens (LAL) — postoperative UV-light power adjustment, but only available if you started with an LAL (not retrofittable). The original surgeon should evaluate any touch-up because they know the original alignment and IOL model best.

3. Key takeaways: 8 things you really need to know

30-second takeaways

Main indication: regular corneal astigmatism ≥ 1.0 D + patient wants spectacle independence; < 0.75 D usually does not need a toric IOL, 0.75–1.0 D is a grey zone
Account for posterior corneal astigmatism (PCA): ignoring PCA is the biggest source of residual astigmatism error — WTR overestimates by ~0.5 D, ATR underestimates by ~0.3 D
Mainstream formulas: Barrett Toric, Abulafia-Koch (both have built-in PCA correction); Barrett True-K Toric for post-LASIK, Barrett True-K KC for keratoconus
Outperforms LRIs: Cochrane 2019 — toric IOL achieves residual astigmatism ≤ 0.5 D in ~70% of eyes vs ~50% for LRIs; mean residual cylinder ~0.3 D lower
Rotation risk is manageable: 90–97% within ±5° of target; overall repositioning rate ~0.65% (6431-eye registry); each 1° off-axis = 3.3% lost correction
Special populations feasible but selective: post-LASIK (Barrett True-K Toric, strict selection), mild-to-moderate KC (stable ≥ 1 yr), post-keratoplasty (custom toric reports favourable), Fuchs/DMEK (over-correction common, use epithelial mapping); use caution in severe PEX
Fully self-pay in Taiwan: NHI covers only standard spherical IOLs; toric/multifocal/EDOF IOLs are 'special materials' (not under the drug coverage regulations), priced as 'NHI + out-of-pocket difference'; cost varies by brand
Open questions: cost-effectiveness evidence is sparse, long-term ≥ 5-yr PROMs lacking, indications for irregular astigmatism remain ill-defined, image-guided vs manual marking health-economics analyses are limited

4. Astigmatism and cataract: background

Astigmatism means the eye's optical system has unequal refractive power along different meridians, so light cannot focus to a single point on the retina. The dominant source is corneal astigmatism (the cornea is ellipsoidal rather than perfectly spherical); a smaller contribution comes from the crystalline lens itself. Regular astigmatism is classified clinically by axis into three subtypes:

Type	Steep axis	Features / epidemiology
With-the-Rule (WTR)	60°–120° (vertical steep)	Predominant in children and young adults; the 'upright cylinder' Rx commonly prescribed
Against-the-Rule (ATR)	0°–30° / 150°–180° (horizontal steep)	Increases with age; predominant in older adults; the majority of cataract patients fall here
Oblique	30°–60° / 120°–150°	Less common; often linked to keratoconus, trauma, post-refractive surgery

Regular vs irregular astigmatism: regular astigmatism has its steepest and flattest meridians perpendicular and can be corrected with a single cylinder power. Irregular astigmatism (keratoconus, trauma, scarring, severe dry eye) lacks this symmetry; a toric IOL cannot fully correct it, and rigid contact lenses or corneal procedures may be needed. Toric IOLs are designed for regular corneal astigmatism — distinguishing the two is a critical preoperative step.

Prevalence: astigmatism is one of the most common refractive errors worldwide. Hashemi et al.'s global meta-analysis: ~14.9% in children rising to 40.4% in adults (≥ 0.5 D threshold). Among cataract surgery candidates the rate is higher — Day et al. (UK) found ~37% have ≥ 1.0 D corneal astigmatism (the typical threshold for toric IOL consideration).

Posterior corneal astigmatism (PCA) matters: early IOL formulas used only anterior keratometric astigmatism (KA), assuming PCA was negligible. Koch et al. (2012) showed PCA is real and non-trivial — predominantly in the ATR direction:

WTR eyes: anterior is WTR + posterior is ATR → they partly cancel, so total corneal astigmatism (TCA) is ~0.5 D less than KA; using KA alone leads to overcorrection
ATR eyes: anterior and posterior point the same way → additive; TCA is ~0.3 D more than KA; using KA alone leads to undercorrection

That's why modern toric IOL calculation must use formulas that estimate or directly measure PCA (Barrett Toric, Abulafia-Koch). PCA neglect is the single largest source of postoperative residual astigmatism error.

5. Indications and exclusions: who's a candidate?

✅ Main indications (international consensus)

Regular corneal astigmatism ≥ 1.0 D (some advocate ≥ 0.75 D, but evidence below 0.75 D is thin)
Patient wants to be as spectacle-free as possible (spectacle independence is part of the goal)
Consistent astigmatism magnitude/axis across imaging modalities (difference ≤ 0.5 D / ≤ 10°, indicating regular and reproducible)
Able to afford the out-of-pocket cost (NHI does not cover in Taiwan) and accept the residual-astigmatism and very-low repositioning risks

⚠️ Relative contraindications / use with caution

Irregular astigmatism (severe keratoconus, surface-irregularity from severe dry eye, traumatic scarring, Salzmann nodular degeneration, severe corneal scarring) — toric IOL cannot fully correct higher-order aberrations
Progressing keratoconus (refractive change in past 12 months, or recent crosslinking) — unstable astigmatism makes calculation unreliable
Severe PEX with marked zonular instability — high risk of late dislocation, axis stability compromised
Unable to cooperate with precise preoperative measurements (severe dementia, unable to fixate)
Unrealistic expectations — patients expecting 'toric guarantees no glasses ever' will be disappointed

6. Preoperative workup SOP

Toric IOL accuracy hinges on preoperative measurement quality. The international consensus workup has five key elements:

Step	Key content
① Ocular surface optimization	Dry eye, MGD, allergic conjunctivitis all disturb keratometry (K-readings 'fluctuate'). Optimize ocular surface 4–6 weeks before (artificial tears, warm compresses, short-course steroid/cyclosporine if needed). → 8 dry-eye myths
② Multi-device cross-check	Optical biometry (IOLMaster 700, Lenstar, Argos) + Pentacam/Scheimpflug ± anterior segment OCT. If ≥ 2 devices disagree by > 0.5 D magnitude or > 10° axis, the astigmatism is 'not regular enough' or measurement is unreliable — don't proceed with toric IOL directly
③ Include posterior corneal astigmatism (PCA)	Use Barrett Toric, Abulafia-Koch (built-in PCA estimation), or directly measure PCA via Pentacam/AS-OCT. PCA neglect is the largest source of residual astigmatism
④ Corneal topography review	Verify a regular bowtie pattern; irregular topographies (keratoconus, irregular post-LASIK, Salzmann's) need expert interpretation and usually special formulas or alternative plans
⑤ Expectation-setting	Honest counselling: (a) residual cylinder won't be zero, 70% reaching ≤ 0.5 D doesn't mean 100%; (b) very rare need for repositioning; (c) multifocal toric carries halo/glare risk; (d) special risks in post-LASIK/KC; (e) full self-pay cost structure in Taiwan

7. IOL calculation formulas: which is most accurate?

Modern toric IOL formulas have proliferated. The Verstraaten review groups them into three categories: (1) Universal — for normal corneas; (2) Post-refractive — for LASIK/SMILE/PRK eyes; (3) Keratoconus-specific. Representative members:

Category	Mainstream formulas	Use / features
Universal	Barrett Toric, Abulafia-Koch, Kane Toric, EVO Toric	Mainstream; all include PCA estimation. Multiple studies show Barrett Toric and Abulafia-Koch perform comparably across populations, both superior to earlier KA-only Holladay/SRK Toric
Post-refractive	Barrett True-K Toric, ASCRS Postrefractive Calculator, Haigis-L Toric	LASIK/PRK altered anterior curvature; standard formulas underestimate corneal power. True-K series corrects with direct posterior K. Run multiple formulas and compare for post-refractive eyes
Keratoconus	Barrett True-K KC (P-PCA / M-PCA), Kane KC, Hoffer-QST KC	KC has steep K (> 47 D); standard formulas overcorrect. KC-specific formulas improve prediction. Tian et al. 2025 meta-analysis: Barrett True-K KC P-PCA performs robustly across KC severity; multi-formula comparison recommended

Online IOL calculators and apps: modern surgeons use online calculators (Barrett Toric official site, ASCRS Online Calculator) or IOLMaster built-in systems; smartphone apps for toric axis marking (Toric Eye CASIA, TrueSight) exist but supplement rather than replace clinical judgment.

8. Outcomes and patient-reported satisfaction

The Verstraaten review aggregates the past decade's key outcome studies. The three pivotal objective metrics are residual refractive astigmatism, UDVA, and spectacle independence:

Residual refractive astigmatism ≤ 0.5 D rate: toric IOL ~70% (Cochrane 2019, Lake et al.); theoretical lower bound ~0.3–0.4 D due to cumulative measurement/SIA/alignment/manufacturing errors
UDVA: most RCTs show toric IOL groups average 20/25–20/30 UDVA, clearly better than non-toric 20/40–20/50 in moderate-to-high cylinder populations
Spectacle independence: monofocal toric ~50–70% of patients fully spectacle-free at distance (varies with viewing distance); multifocal toric reaches 80–90% but at the cost of halos/glare

PROMs (patient-reported outcomes): common instruments include NEI-RQL 42, VFQ-25, Catquest-9SF. Mencucci et al. 2013 showed toric IOL patients score significantly higher on NEI-RQL 42 'expectations met' and 'satisfaction with eye health.' The ESCRS group flagged that long-term (≥ 5 yr) PROM data remain sparse — an important research priority.

Dysphotopsia is the most common patient complaint. Pusnik et al. 2022 review summarized:

Positive dysphotopsia (halos, starbursts, glare): up to 67% early postop; persistent at 1 year ~2%; rare need for surgical remediation (0.07%)
Negative dysphotopsia (peripheral arc shadow): acute ~26%; persistent long-term only 0.1–3%
Monofocal toric photic phenomena are similar to standard monofocals; multifocal toric has significantly higher halo/glare rate (~50%, Visser et al. 2011), mostly mild

9. Toric IOL vs LRI vs FSAK: how to choose?

Three options for managing astigmatism at the time of cataract surgery: (1) Toric IOL — cylinder built into the IOL; (2) LRI (Limbal Relaxing Incisions) — paired arcuate cuts at the limbus releasing astigmatism; (3) FSAK (Femtosecond Laser-Assisted Astigmatic Keratotomy) — precise femto-laser arcuate corneal incisions. Evidence comparison:

Comparison	Toric IOL	LRI (manual)	FSAK (femto)
Astigmatism range	1.0–8.0 D (some brands up to 12.0 D)	0.5–2.5 D (accuracy degrades higher)	0.75–3.5 D
Residual ≤ 0.5 D rate	~70% (Cochrane 2019)	~50% (Cochrane 2019)	~50–60% (Yen 2025, Zhuo 2023)
Long-term stability	High; rare rotation can be repositioned	Moderate; may regress	Moderate-to-high; depends on equipment
Corneal health impact	None; cornea untouched	Small; possible mild epithelial defect	Small; more precise than LRI, may still delay epithelial healing
Cost (Taiwan)	High (full self-pay IOL difference)	Low (some centers bundle, no extra fee)	Moderate-to-high (femto laser fee usually separate)

Practical guide: astigmatism ≥ 1.5 D — toric IOL usually beats LRI/FSAK; < 1.0 D — LRI/FSAK as cheaper alternative; 1.0–1.5 D is a grey zone where toric or LRI + standard IOL (or combined) are both reasonable. FSAK has an edge in special populations requiring extreme alignment precision (post-LASIK) but at higher cost. Final decision is individualized.

10. Toric IOL design, material, and intraoperative alignment

The Verstraaten review highlights that IOL design and material significantly affect rotational stability. Key parameters: haptic shape, IOL diameter, material, and surface treatment:

Haptic design: plate haptic (board-like, ~11 mm diameter) vs C-loop haptic (~13 mm). Trade-offs: plate has less rotation but higher PCO after capsular fibrosis; C-loop has easier precise alignment but slightly higher theoretical rotation. Recent 'frosted haptic' surface treatment (e.g., Tecnis Toric II) significantly reduces rotation (mean absolute rotation < 1° at 3 months)
Material: (1) Hydrophobic acrylic — strong capsular adhesion, least rotation, lowest PCO; current mainstream. (2) Hydrophilic acrylic — good foldability but slightly higher PCO and posterior capsular calcification risk. (3) Silicone — less used; slightly higher posterior capsule infection/injury risk. (4) PMMA — rigid, needs large incision, higher PCO; mostly historical
Single-piece vs three-piece: modern toric IOLs are almost universally single-piece, more stable, with smaller incision (2.2 mm mainstream); three-piece designs reserved for sulcus implantation or special situations

Intraoperative alignment method is the make-or-break step. Per the Verstraaten review:

Alignment method	Principle	Accuracy
Manual ink marking	Patient sitting upright, mark 0°/180° at limbus with ink, align with intraoperative gauge	Mean error ~3–5°; cheapest, accuracy limited by ink spread, positioning, surgeon's eye
Image-guided digital systems (Verion, Callisto Eye, TrueGuide, etc.)	Preoperative iris/vessel image registered; intraoperative overlay on microscope view, auto-tracks	Mean error ~2–3°; Panagiotopoulou et al. 2019 systematic review shows superior precision over manual. Cost is the main limitation

3.3% lost correction per 1° off-axis is the consensus 'golden rule.' Translation: 5° off = ~17% lost, 10° off = ~33% lost, 30° off = zero correction, > 30° off = induces astigmatism in the opposite axis. This is why the ESCRS group strongly recommends image-guided alignment for moderate-to-high cylinder cases.

11. Rotational stability, repositioning timing, other complications

The literature on toric IOL rotational stability is now comprehensive. Key numbers:

Study	Design	Key results
Singh et al. 2022	Prospective observational (30 eyes, 6 mo)	95% within ±5° at 6 months; most rotation occurs in the first month
Hoffmann et al. 2025	Prospective RCT (15 centers, 299 eyes, 4 toric IOL models)	All models stable at 4–6 months; 90–97% within ±5° depending on model; 4–8% exceed 10° in select outliers
Lee and Chang 2018	Retrospective cohort (1273 eyes, single practice)	Day 1： 82–92% within ±5°; hydrophobic acrylic mean rotation 2.7°, hydrophilic 3.8°; 1.6–3.1% need repositioning
Oshika et al. 2018	Retrospective multicenter case series (6431 eyes)	0.65% (42/6431) needed repositioning; mean off-axis 33°; best repositioning timing ≥ 7 days postop (final misalignment 6° vs 13° for earlier reposition)

💡 Optimal timing of IOL repositioning

Too early (within 1–2 days): capsular bag has not started fibrosing, IOL can drift, prone to re-rotation
Sweet spot (7–14 days): initial capsular fibrosis 'locks in' the IOL post-repositioning
Too late (> 4 weeks): capsular fibrosis is well advanced, IOL hard to rotate, theoretical zonular stress risk
Safety of repositioning: Oshika et al.'s 42-eye series reported no sight-threatening complications; possible adverse events include transient IOP elevation, CME, repeat dislocation, hemorrhage or inflammation, endothelial cell loss

Decentration and tilt: centration and planarity also matter. Clinically symptomatic decentration is uncommon if the capsulorhexis fully overlaps the IOL edge 360°. Mild decentration (< 0.5 mm) or tilt (< 5°) has minimal visual impact. Severe decentration may require recentration or exchange.

Postoperative behavior: traditional advice includes avoiding strenuous activity, sleeping face-down, or rubbing eyes for 1–2 weeks. But Jandewerth et al. 2025 (for non-toric IOL) found 'walking vs lying' postop didn't affect IOL rotation. Toric-specific behavioral guidelines remain lacking; current advice mostly mirrors general post-cataract recovery.

12. Special populations

The ESCRS review dedicates substantial space to special populations where toric IOLs remain feasible but require more careful preoperative assessment, special formulas, and managed expectations.

(1) Post-refractive surgery (LASIK / SMILE / PRK)

Standard keratometry underestimates corneal power (anterior surface altered by laser). Must use formulas using direct posterior measurement (Barrett True-K Toric) or the ASCRS online calculator, with strict selection criteria:

Regular bowtie pattern within central 3.0 mm zone
Magnitude difference ≤ 0.75 D across imaging modalities
Axis difference ≤ 15° across modalities
Multi-formula comparison; counsel that 'mild glasses or future touch-up may still be needed'

(2) Keratoconus

Criteria: (1) stable ≥ 1 year; (2) mild-to-moderate KC; (3) reproducible refraction; (4) use KC-specific formulas (Barrett True-K KC P-PCA/M-PCA, Hoffer-QST KC). Yahalomi et al. 2022 meta-analysis: in selected mild-to-moderate KC, toric IOLs significantly improve UDVA and BCVA; hydrophobic acrylic remains stable even in high myopia (consider capsular tension ring). KC heterogeneity demands multi-formula and multi-device cross-validation.

(3) Pseudoexfoliation syndrome (PEX)

PEX makes cataract surgery harder: poorly dilating pupils, zonular instability, more postoperative inflammation. For toric IOLs the biggest issue is late spontaneous IOL dislocation — PEX is the leading cause, often within 5–10 years of surgery. Dislocation equals total loss of axis alignment. PEX eyes are also prone to capsular phimosis, zonular weakening, and IOL decentration. Refractive surprise > 1.0 D is significantly more likely. Use toric IOL with caution; ensure informed consent.

(4) Post-keratoplasty (PK / DALK)

Wan et al. 2022 systematic review of 7 studies, 106 post-keratoplasty eyes with toric IOL: refractive astigmatism reduced 52.5–74.6%; 50–100% achieved residual ≤ 1.0 D; UDVA ≥ 20/40 in 61.5–100%. Safety acceptable, only 1% needed rotation. Custom toric IOLs (personalized) maintain stability in PK/DALK with all alignments within ±10°. Endothelial cell loss 5.6–22.3%. Conclusion: in selected patients with custom toric, toric IOL is reasonable and effective post-keratoplasty.

(5) Fuchs endothelial dystrophy + triple DMEK

In FECD patients needing both cataract surgery and endothelial keratoplasty (e.g., DMEK), triple DMEK (cataract + toric IOL + DMEK in one operation) is an option. Yokogawa 2017, Trindade 2021 show favorable outcomes, with UDVA slightly inferior to standard cataract. Challenge: overcorrection is common in WTR eyes because residual posterior ATR persists. Recommendations: (1) combine biometric data and toric calculator outputs; (2) add AS-OCT epithelial mapping; (3) temporal incision; (4) re-verify IOL alignment after DMEK graft fixation; (5) implanting toric IOL before clinical corneal edema may improve predictability.

13. Taiwan context: NHI vs self-pay structure

⚠️ Important: Toric IOL is NOT NHI-covered in Taiwan

Taiwan NHI's drug-coverage rules do not include IOLs — IOLs are medical devices under a separate 'special materials' framework. Toric IOL is out-of-pocket in Taiwan; for actual cost structure and the cost difference vs the standard NHI IOL, refer to your hospital's pre-service notice.

Standard spherical IOL: partially NHI-covered (surgery fee + standard lens)
Toric / multifocal / EDOF / trifocal / LAL IOLs: fully self-pay (priced as 'NHI portion + patient pays the difference')
Cost varies widely by brand and bundling with multifocal/EDOF design. We don't quote prices — ask your ophthalmologist or clinic directly

Postoperative medications: NHI-covered (April 2026 regs)

§14.4.1 ophthalmic quinolones (moxifloxacin/levofloxacin): postoperative infection prophylaxis, NHI-covered
§14.8 ophthalmic ketorolac (topical NSAID): post-cataract anti-inflammatory, NHI-covered
(Postoperative topical steroids — dexamethasone, prednisolone, loteprednol — are also NHI-covered)

💡 Budget-friendly alternatives

Option 1 (cheapest): standard spherical IOL (NHI-covered) + post-op cylinder glasses → astigmatism corrected by glasses
Option 2: standard IOL + simultaneous LRI (some centers offer, may be bundled) → partial astigmatism correction, may still need some glasses
Option 3: self-pay toric IOL (monofocal toric cheaper than multifocal toric) → astigmatism corrected by IOL

Key point: don't choose 'upgrade' IOLs just because the name sounds premium. Base the decision on your actual corneal astigmatism, lifestyle, budget, and individualized discussion with your doctor.

Further reading: this article focuses solely on toric IOL. For overall cataract surgery decisions (modality, IOL classification, monovision, NHI vs self-pay, scenarios), see Cataract Surgery Selection. For basic cataract knowledge (what is cataract, when to operate, preoperative prep), see Cataract Surgery Patient Education.

14. 5 common myths

Myth 1： 'Anyone with astigmatism should get a toric IOL for cataract surgery'

Fact: astigmatism < 0.75 D usually does not need a toric IOL; the benefit is small. < 1.0 D is a grey zone. The decision depends on astigmatism magnitude, regularity, tolerance for glasses, and budget. Don't pick the priciest option because of clinic sales talk.

Myth 2： 'A toric IOL guarantees no more glasses'

Fact: only ~50–70% (monofocal toric) or ~80–90% (multifocal toric) become fully glasses-free. Cochrane meta-analyses show ~70% achieve residual ≤ 0.5 D, meaning ~30% have > 0.5 D residual and may need mild glasses. Different tasks (reading, phone, night driving) have different needs. Toric IOL substantially reduces glasses dependence but doesn't guarantee zero glasses.

Myth 3： 'After a toric IOL you can never have a laser touch-up'

Fact: yes you can. If significant residual cylinder or sphere remains after 3 months, options include LASIK enhancement, PRK; larger errors can be addressed with IOL exchange or piggyback IOL. Light Adjustable Lens (LAL) allows postoperative UV-light adjustment but must be chosen at original surgery. Discuss with the original surgeon.

Myth 4： 'Self-pay toric IOLs must be safer or higher quality than NHI standard IOLs'

Fact: the out-of-pocket cost reflects added astigmatism-correction value, not 'overall higher IOL safety.' Standard spherical IOLs perform their core cataract function safely and effectively. Toric IOLs add astigmatism correction but also add complexity (precise alignment, very rare repositioning). If your astigmatism is small, budget is limited, and you accept glasses, standard IOL is entirely reasonable.

Myth 5： 'IOL rotation means the surgeon was bad'

Fact: rotation is multifactorial — beyond intraoperative alignment, it's affected by IOL design (haptic shape, material), IOL-to-bag size matching, capsulorhexis size, residual viscoelastic, patient behavior, capsular fibrosis pattern, PEX or other pathology. Even the most experienced surgeon with the most advanced image-guided system and the newest hydrophobic acrylic IOL has a 0.5–3% rotation rate. The key is early detection and timely repositioning — 7–14 days postop is optimal. If your vision is below expectations after surgery, tell your ophthalmologist to check IOL alignment.

15. Advanced topics: open questions and future directions

The ESCRS working group honestly lists open questions in toric IOL practice for the curious reader:

Cost-effectiveness evidence is sparse: health-economic analyses comparing toric IOL vs LRI or no correction in 'long-term glasses savings, reduced secondary procedures, QoL gains' are few. This matters for policy and insurance decisions
Long-term (≥ 5 yr) PROM data lacking: most studies follow only 6 months to 2 years; longer-term visual quality, satisfaction, and QoL need extended follow-up
Indications for irregular astigmatism remain ill-defined: mild irregularity (mild KC, mild post-LASIK irregularity, borderline dry eye) — RCT evidence for toric IOL applicability is scarce
Low astigmatism (0.75–1.5 D) toric IOL benefit: Buscacio et al. 2016 (small study) showed benefit in low cylinder, but large RCT confirmation lacking; ESCRS is running the TORIC trial to address
Image-guided vs manual alignment cost-effectiveness: image-guided's superior precision is established, but 'equipment cost vs accuracy gain' value-for-money analyses are limited
Surgeon education and standardization: toric IOLs turn cataract surgery into refractive surgery, requiring corneal astigmatism evaluation, precise alignment, and touch-up skills. Society guidelines are evolving; practice variation persists

16. Summary: 5 questions to ask your doctor

💬 5 questions to ask at your consultation

'What is my corneal astigmatism in diopters? Is it WTR, ATR, or oblique? Regular or irregular?'
'For my level of astigmatism, do you recommend toric IOL, LRI, or standard IOL + glasses? Why?'
'What's the estimated residual astigmatism after surgery? Will I need glasses? What will distance vs near be like?'
'What's your intraoperative alignment method — manual marking or image-guided? What's your repositioning rate for toric IOLs?'
'I have (post-LASIK / KC / PEX / Fuchs, etc.) — does this affect my toric IOL options and outcomes? Which formula will you use?' (Tailor to your situation)

Closing: by 2026, toric IOLs have moved from 'premium option' to 'mainstream recommendation for moderate-to-high astigmatism cataract patients.' International reviews confirm that with well-selected patients, precise preoperative measurement, appropriate formulas, and accurate intraoperative alignment, toric IOLs are safe and effective, substantially improving postoperative UDVA and quality of life. But this isn't a panacea — residual astigmatism isn't zero, very rare cases need repositioning, the full self-pay cost in Taiwan is non-trivial, and irregular astigmatism and special populations still need careful assessment. The final decision is always an individualized 'your astigmatism + your lifestyle + your budget + your surgeon's judgment.' Wishing you a clear, comfortable visual recovery.

📚 HsiaoEye Cataract Series

Cataract Surgery — Patient Education — Basics, symptom ID, when to operate, preoperative prep
Cataract Surgery Deep Selection — 3 modalities, IOL classes, NHI vs self-pay
Toric IOL for Astigmatism — Full Guide — Indications, outcomes, rotation, special populations (you are here)

References

Verstraaten JWH, Buzzi M, Masalkhi M, Behndig A, Cochener B, Day AC, Dick HB, Findl O, Lapid-Gortzak R, Kohnen T, Nuijts R, Rosen P, van den Biggelaar FJHM, Abulafia A, Virgili G, Dickman MM. Correcting Astigmatism Using Toric Intraocular Lenses During Cataract Surgery. Am J Ophthalmol. 2026;286:248–262.
Kessel L, Andresen J, Tendal B, et al. Toric intraocular lenses in the correction of astigmatism during cataract surgery: a systematic review and meta-analysis. Ophthalmology. 2016;123(2):275–286.
Lake JC, Victor G, Clare G, et al. Toric intraocular lens versus limbal relaxing incisions for corneal astigmatism after phacoemulsification. Cochrane Database Syst Rev. 2019;12:CD012801.
Al-Mohtaseb Z, Steigleman WA, Pantanelli SM, et al. Toric monofocal intraocular lenses for the correction of astigmatism during cataract surgery: a report by the American Academy of Ophthalmology. Ophthalmology. 2024;131(3):383–392.
Hashemi H, Fotouhi A, Yekta A, et al. Global and regional estimates of prevalence of refractive errors: systematic review and meta-analysis. J Curr Ophthalmol. 2018;30(1):3–22.
Day AC, Dhariwal M, Keith MS, et al. Distribution of preoperative and postoperative astigmatism in a large population of patients undergoing cataract surgery in the UK. Br J Ophthalmol. 2019;103(7):993–1000.
Koch DD, Ali SF, Weikert MP, et al. Contribution of posterior corneal astigmatism to total corneal astigmatism. J Cataract Refract Surg. 2012;38(12):2080–2087.
Abulafia A, Barrett GD, Kleinmann G, et al. Prediction of refractive outcomes with toric intraocular lens implantation. J Cataract Refract Surg. 2015;41(5):936–944.
Oshika T, Inamura M, Inoue Y, et al. Incidence and outcomes of repositioning surgery to correct misalignment of toric intraocular lenses. Ophthalmology. 2018;125(1):31–35.
Hoffmann P, Potvin R, Anello RD, et al. Comparing rotational stability over time between four monofocal toric intraocular lenses. Clin Ophthalmol. 2025;19:1345–1355.
Lee BS, Chang DF. Comparison of the rotational stability of two toric intraocular lenses in 1273 consecutive eyes. Ophthalmology. 2018;125(9):1325–1331.
Singh VM, Ramappa M, Murthy SI, et al. Toric intraocular lenses: expanding indications and preoperative and surgical considerations to improve outcomes. Indian J Ophthalmol. 2022;70(1):10–23.
Pusnik A, Petrovski G, Lumi X. Dysphotopsias or unwanted visual phenomena after cataract surgery. Life (Basel). 2022;13(1):53.
Abulafia A, Hill WE, Koch DD, et al. Accuracy of the Barrett True-K formula for intraocular lens power prediction after laser in situ keratomileusis or photorefractive keratectomy for myopia. J Cataract Refract Surg. 2016;42(3):363–369.
Wan KH, Chang JSM, Jhanji V. Toric intraocular lenses for astigmatism correction after keratoplasty in phakic and pseudophakic eyes. J Cataract Refract Surg. 2022;48(9):1078–1087.
Yahalomi T, Achiron A, Hecht I, et al. Refractive outcomes of non-toric and toric intraocular lenses in mild, moderate and advanced keratoconus: a systematic review and meta-analysis. J Clin Med. 2022;11(9):2456.
Yen WT, Weng TH, Lin TY, et al. Femtosecond laser-assisted astigmatic keratotomy versus toric IOL implantation for correcting astigmatism in cataract patients: a systematic review and meta-analysis with trial sequential analysis. Br J Ophthalmol. 2025;109(3):324–332.

Toric IOL for Cataract — Is It Worth It? Who, How Well, What Risks